0001127602-23-002141.txt : 20230124
0001127602-23-002141.hdr.sgml : 20230124
20230124173328
ACCESSION NUMBER: 0001127602-23-002141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230120
FILED AS OF DATE: 20230124
DATE AS OF CHANGE: 20230124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watson David O.
CENTRAL INDEX KEY: 0001657719
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 23549171
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-01-20
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657719
Watson David O.
C/O APELLIS PHARMACEUTICALS, INC
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
General Counsel
Common Stock
2023-01-20
4
F
0
2034
52.05
D
166990
D
Common Stock
3333
I
Indirect Owner (Custodial Account for Son)
Common Stock
6667
I
Indirect Owner (The Watson Education Trust)
This represents shares withheld for tax on a restricted stock unit release.
This represents a custodial account held by the reporting person for the sole benefit of his minor son.
The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.
David Watson
2023-01-24